Why Shares of Belite Bio Soared This Week
The clinical-stage biotech company bounced back from a 52-week low late last week.
Why Shares of Belite Bio Are Slumping Wednesday
The biopharmaceutical company announced a stock sale that's not great news to current investors.
3 Breakout Growth Stocks to Buy for the Long Haul
These three have had big-time share gains backed up by breakthrough science.
2 Stocks Up 165% and 209% in 2022 That Could Keep Soaring in 2023
Find out how these stock rockets could continue their ascent.
3 Soaring Biotech Stocks That Could Climb Much Higher
These drugmakers have bucked the overall market's downward trend this year and expectations are still high.